The G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies market size is expected to reach $2.42 billion in 2030 at a CAGR of 32.9%, driven by rising myeloma prevalence.
Read More
The Epitranscriptomic Therapies market size is expected to reach $4.2 billion in 2030 at a CAGR of 21.9%, driven by increasing demand for personalized medicine.
Read More
The Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology market size is expected to reach $8.77 billion in 2030 at a CAGR of 23.5%, driven by rising adoption of genomics and personalized medicine.
Read More
The Epidermal Growth Factor Receptor (EGFR) Non-Small Cell Lung Cancer market size is expected to reach $13.74 billion in 2030 at a CAGR of 8.1%, driven by increasing focus on personalized medicine approaches.
Read More
The Dual-Chamber Serum Bottle market size is expected to reach $1.98 billion in 2030 at a CAGR of 7.9%, driven by rising demand in cosmetics and personal care.
Read More
The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery market size is expected to reach $15.22 billion in 2030 at a CAGR of 12.5%, driven by rising demand for personalized medicine.
Read More
The Clear Cell Ovarian Cancer market size is expected to reach $3.15 billion in 2030 at a CAGR of 8.5%, driven by increasing adoption of targeted therapies.
Read More
The Chlorhexidine Mouth Rinse market size is expected to reach $1.52 billion in 2030 at a CAGR of 7.1%, driven by increasing prevalence of oral diseases.
Read More
The Cell-Based Biological Reagents market size is expected to reach $20.74 billion in 2030 at a CAGR of 8.6%, driven by growing cell and gene therapy demand.
Read More
The Cell Sheet-Based Gene Therapy market size is expected to reach $1.34 billion in 2030 at a CAGR of 14.6%, driven by increasing chronic disease prevalence.
Read More